Pharmaron | Briefing, News, Analysis, Research, Data

Pharmaron

Pharmaron and is committed to helping partners succeed in drug discovery'

Pharmaron is a global pharmaceutical company, biotech company and research institute that provides fully integrated drug discovery, development and manufacturing CRMO solutions across the two stages of drug discovery and drug development, and is committed to helping partners succeed in drug discovery, development and commercialization.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jan 1, 2003

HQ location

Beijing, China

Legal name

Pharmaron Beijing Co., Ltd.

Website

http://www.pharmaron.com/

pharmaron@pharmaron-bj.com

Employees

1001-5000

All
News
Analysis
Research

Briefing Jun 24, 2022 10:39 AM · Technology | Healthcare | Industrials

The maximum payment limit of employee medical insurance in Shanghai in 2022 was raised to 590000 yuan

Briefing Jun 07, 2022 10:37 AM · Healthcare | Real Estate | Industrials

The port sector continued to strengthen and Guangzhou port rose by the daily limit

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Apr 26, 2022 10:40 AM · Consumer Staples | Healthcare | Industrials

Runfeng shares: exchange rate changes have little impact on the company's performance

Briefing Apr 19, 2022 11:34 AM · Consumer Staples | Healthcare | Financials

The steel plate rose and Jinling mining rose by the limit

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Financials, Technology

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Mar 10, 2022 09:49 AM · Healthcare | Financials | Automotive

Traditional Chinese medicine stocks rose and strengthened, and Dali pharmaceutical touched the daily limit

Briefing Feb 25, 2022 10:38 AM · Technology | Healthcare | Financials

"Zhongke spectral light" completed tens of millions of yuan of round a financing

Briefing Feb 21, 2022 10:29 AM · Healthcare

Baidu responded that it was unable to search "referee document network": caused by misoperation of the technical team

Briefing Feb 16, 2022 01:29 PM · Consumer Staples | Healthcare | Automotive

According to the needs of epidemic prevention and control, the operation of Suzhou passenger transport line was suspended

Healthcare

BociMed Closed CNY 100 Mn in A New Financing Round

After this financing, BociMed will implement business restructuring and specify the focus of subsidiary and parent company

Feb 16, 2023 12:16 PM

Healthcare

Innovative Drug Developer Micot Nets Over CNY 100 Mn in Series C

The innovative drug company has raised over CNY 500 million to become a world-leading polypeptide drug developer

Feb 10, 2023 05:52 PM

Briefing Feb 15, 2022 10:49 AM · Technology | Communication | Consumer Discretionary

The whole vehicle sector rose in shock, and Shuguang shares closed the limit

Briefing Feb 08, 2022 04:50 PM

GAC group: in January, the automobile sales volume was about 237200, with a year-on-year increase of 9.16%

Briefing Feb 08, 2022 09:39 AM · Consumer Staples | Healthcare | Financials

The digital currency sector opened sharply lower

Healthcare

Qiming-Backed Hochuen Medical Bags Over CNY 10 Mn in Series B Round

Microfluidics technology, at the core of point-of-care testing (POCT), has huge potential for growth.

Feb 08, 2023 04:50 PM

Healthcare

Hemay Pharmaceutical Nets Nearly CNY 300 Mn in Series D

The innovative drug company aims to provide more effective, affordable, safer medicine for patients

Feb 08, 2023 11:21 AM

Briefing Jan 26, 2022 01:19 PM · Consumer Staples | Healthcare | Automotive

Kia's fourth quarter sales were 17.19 trillion won, lower than expected

Briefing Jan 25, 2022 07:30 PM · Technology | Automotive

GE's total revenue in the fourth quarter was $20.3 billion and is expected to be $21.4 billion.

Briefing Jan 25, 2022 05:40 PM · Technology | Consumer Staples

First environmental protection: it is proposed to issue renewable corporate bonds of no more than 6 billion yuan

Briefing Jan 21, 2022 07:29 PM · Technology | Healthcare | Financials

Jinyuan shares: Xu Gang, chairman of the board, plans to increase his holding of shares of no less than 15 million yuan

EqualOcean Analysis